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Accepted 3 June 2014A 76-year-old married woman, gravida 4, para 4, who went
through menopause at the age of 50 years, with hypertension and
diabetes under fair control, was admitted to the general surgery
ward of Taichung Veterans General Hospital, Taichung, Taiwan due
to a self-palpable right inguinal nodule that had persisted for more
than 1 month. A physical examination revealed a tender nodule
about 3 cm in size over the right groin area. There was no swelling,
local heat, or erythematous change. Abdominopelvic computed
tomography (CT) showed a right inguinal hernia with a mild in-
ﬂammatory process in the lower abdomen (Fig. 1). She underwent
hernioplasty with high ligation of the inguinal sac and mesh
prosthesis. During the operation, an indirect hernia sac with
incarcerated omentum was found. Pathology of the inguinal sac
and a small tissue sample of the omentum both revealed high-
grade metastatic serous carcinoma, and gynecological cancer was
highly suspected. Therefore, she was transferred to our clinic,
where a bimanual examination revealed a smooth cervix. Ultraso-
nography showed a normal-sized uterus, a thin endometrium,
bilateral small adnexae, and no ascites. Laboratory tests showed an
elevated level of tumor marker CA-125: 159 U/mL. Other tests
including whole blood cell count, biochemistry, and chest X-ray
were normal.
She then underwent exploratory laparotomy. The bilateral
ovaries and fallopian tubes were grossly normal, and there was no
obvious ascites. There were multiple tiny tumors seeded in the* Corresponding author. Department of Obstetrics and Gynecology, Taichung
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than 5 mm. Other tiny tumors seeded over the anterior cul-de-sac
and uterine serosa were found, with the largest one measuring
1  1  0.5 cm3. There were also tiny tumors seeded in the upper
portion of the ascending colon. The lower end of the omentum
adhered to the right hernioplasty wound, the appendix looked
unremarkable, and the subdiaphragm and liver surface were
smooth by palpation. She underwent total abdominal hysterec-
tomy, bilateral salpingo-oophorectomy, pelvic lymph node dissec-
tion, para-aortic lymph node sampling, appendectomy, infracolic
omentectomy, and complete resection of visible intra-abdominal
metastases. Because there were no gross residual tumors, the
procedure was designated as optimal debulking. The ﬁnal patho-
logical diagnosis was Stage IIIB serous carcinoma and intra-
epithelial carcinoma of the right fallopian tube (Fig. 2), with
metastasis to the uterine serosa, left fallopian tube, peritoneum,
omentum, and sigmoid colon.
After the 1st postoperative week, she received six consecutive
courses of chemotherapy, with 135 mg/m2 paclitaxel (Taxol;
Bristol-Myers Squibb, Wallingford, CT, USA) and carboplatin (Par-
aplatin; Bristol-Myers Squibb, Princeton, NJ, USA), with an area
under the curve of 5 mg/mL/min, administered at 3-week intervals.
The tumor marker level dropped to a normal range after the
operation, and after chemotherapy abdominopelvic CT showed no
residual tumors. She received regular follow-up at our outpatient
department, where an elevated CA-125 level of up to 116 U/mL was
noted 7 months after the last course of chemotherapy. She also
complained of a poor appetite, and tumor recurrence was highly
suspected. She therefore received chemotherapy with 20 mg/m2
pegylated liposomal doxorubicin (Lipo-Dox; TTY Biopharm Co. Ltd.,
Taipei, Taiwan) and 2000mg/m2 gemcitabine HCl (Gemzar; Eli Lilly,
Indianapolis, IN, USA) administered at 2-week intervals for a total
of 11 courses. After she had completed the chemotherapy, she was
followed up at our outpatient department, andwas still disease free
4 years after the salvage chemotherapy.
Inguinal hernia is a common condition, and its prevalence in the
elderly population is approximately 6% [1]. Other pathologicalby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Abdominal computed tomography axial view shows right inguinal herniation
with peritoneal fatty component inside the hernia sac.
Fig. 2. Hematoxylin and eosin (40) stain shows partial involvement of the fallopian
tube mucosa by pseudostratiﬁed and hyperchromatic cells. Marked pseudos-
tratiﬁcation was associated with striking nuclear pleomorphism and high nucleocy-
toplasmic ratio of cells. Mitotic activity was increased.
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dermoid cysts, endometriosis, uterine leiomyoma, ovarian cysts,
bladder diverticulum, and malignancy [2e4]. Malignant tumors
presenting in inguinal hernias are rare, occurring in < 0.4% of cases
[5]. The primary tumor may be of colonic origin, which is the most
commonly observed site. Other possible sites are the ovaries,
prostate, mesothelium, appendix, peritoneum, stomach, bile duct,
tonsils, and rectum [6e8]. Twelve cases of ovarian neoplasms
presenting as inguinal hernias have been reported in the English
language literature obtained through a PubMed search. There are
different stages and cell types, such as adenocarcinoma, malignant
mixed mullerian tumor, or clear cell carcinoma [9e11]. However,
there has never been a reported case of primary fallopian tube
carcinoma (PFTC) presenting as an inguinal hernia. The preopera-
tive diagnosis of malignancy within an inguinal sac is rarely made
even with a CT scan. Some authors believe that a routine patho-
logical examination of the excised hernia sacs is not cost effective
and should be performed only in selected cases such as an irre-
ducible hernia, rapidly enlarging hernia, and suspicious lesions
[12]. However, occult malignancies have also been reported in
grossly normal hernia sacs [13,14]. Therefore, routine microscopic
examination of the hernia sac should be considered.PFTC is a rare tumor that histologically and clinically resembles
epithelial ovarian cancer. More than 90% of fallopian tube carci-
nomas are papillary serous adenocarcinomas, and most cases of
PFTC are detected incidentally during exploratory laparotomy. A
deﬁnite preoperative diagnosis is made in only 3e15% of patients.
PFTC should be considered in the following clinical situations:
postmenopausal bleeding or spotting with negative diagnostic
curettage; smear showing abnormal cells or glands alternating
with a negative smear; and unusual, unexplained or persistent
serosanguineous vaginal discharge [15]. Serum CA-125 is a useful
tumor marker for the diagnosis, assessment of response to treat-
ment, and detection of tumor recurrence during follow-up [16].
PFTC is usually managed in the same manner as ovarian cancer
[17]. Surgery is the deﬁnitive treatment, and aggressive cytore-
ductive surgery is mandatory. Postoperative adjuvant chemo-
therapy similar to that used for epithelial ovarian carcinoma usually
involves the prescription of intravenous paclitaxel and carboplatin.
Treatment regimens for recurrent disease are the same as that for
ovarian cancer. In platinum-sensitive patients, deﬁned as women
who relapse later than 6 months after the last course of chemo-
therapy, carboplatin and liposomal doxorubicin are now widely
used for recurrent disease [18]. For patients who are partially
sensitive to platinum (treatment-free interval 6e12 months),
combination chemotherapy with pegylated liposomal doxorubicin
and gemcitabine is well tolerated, with acceptable toxicity and
clear activity based on different mechanisms of cytotoxicity, lack of
cross-resistance with other agents, low-level and nonoverlapping
toxicity, and synergistic preclinical antiproliferative activities [19].
In conclusion, this is the ﬁrst report of fallopian tube carcinoma
with an initial presentation of inguinal hernia. An inguinal hernia in
elderly women may be a sign of occult malignancy with peritoneal
seeding. Careful history taking and physical and pelvic examina-
tions are mandatory. Imaging studies should also be obtained.
Pathological examination of the inguinal sac must be considered in
selected patients.Conﬂicts of interest
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